1. Home
  2. MNPR vs NGS Comparison

MNPR vs NGS Comparison

Compare MNPR & NGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

N/A

Current Price

$70.28

Market Cap

587.4M

Sector

Health Care

ML Signal

N/A

Logo Natural Gas Services Group Inc.

NGS

Natural Gas Services Group Inc.

N/A

Current Price

$28.79

Market Cap

473.6M

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
MNPR
NGS
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oilfield Services/Equipment
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
587.4M
473.6M
IPO Year
2019
2006

Fundamental Metrics

Financial Performance
Metric
MNPR
NGS
Price
$70.28
$28.79
Analyst Decision
Strong Buy
Buy
Analyst Count
12
3
Target Price
★ $130.17
$53.67
AVG Volume (30 Days)
★ 127.0K
93.3K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
★ 2.22%
EPS Growth
★ 54.99
14.60
EPS
N/A
★ 1.26
Revenue
N/A
★ $172,315,000.00
Revenue This Year
N/A
$27.81
Revenue Next Year
N/A
$15.71
P/E Ratio
★ N/A
$22.93
Revenue Growth
N/A
★ 9.94
52 Week Low
$50.07
$26.39
52 Week High
$124.82
$44.61

Technical Indicators

Market Signals
Indicator
MNPR
NGS
Relative Strength Index (RSI) 42.77 43.18
Support Level $66.88 $26.39
Resistance Level $75.33 $33.75
Average True Range (ATR) 4.74 1.61
MACD 0.73 0.04
Stochastic Oscillator 51.81 36.76

Price Performance

Historical Comparison
MNPR
NGS

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.

About NGS Natural Gas Services Group Inc.

Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. It operates in one reporting segment. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.

Share on Social Networks: